Lunai Bioworks (LNAI) Revenue (2013 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Revenue of $20942.0 in Q1 2026, up 8482.79% quarter-over-quarter from $244.0 in Q2 2016.
Lunai Bioworks (LNAI) Revenue (2013 - 2026) Analysis & Trends
Lunai Bioworks' Revenue history runs 3 years deep, the most recent figure standing at $20942.0 for Q1 2026.
- In Q1 2026, Revenue changed N/A year-over-year to $20942.0; the TTM figure through Mar 2026 stood at $53669.0 (changed N/A YoY), while the FY2016 annual figure was $42769.0, changed N/A from the prior year.
- Revenue was $20942.0 for Q1 2026 at Lunai Bioworks, up from $244.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $20942.0 in Q1 2026 to a low of $20942.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,942.00 |
| Jun 30, 2016 | 244.00 |
| Sep 30, 2013 | 925.00 |
| Jun 30, 2013 | 31,558.00 |
| Mar 31, 2013 | 31,558.00 |